Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Santiago Viteri"'
Autor:
M. Phillip DeYoung, James Vasquez, Vladimir Kostorov, Sergey Orlov, David Bellovin, Pilar Garrido López, Evgeny Levchenko, Li Yan, Shirish M. Gadgeel, Hedy L. Kindler, Jose Manuel Trigo, Manuel Domine, Marjorie G. Zauderer, Jan H.M. Schellens, Dean A. Fennell, Xiaowei Wang, Katherine Baker-Neblett, Santiago Viteri, Daniel Morgensztern, Emilie M.J. van Brummelen, Johan Vansteenkiste, Ionel Mitrica
Publikováno v:
Invest New Drugs
BACKGROUND: Fibroblast growth factors (FGFs) have a fundamental role in cancer. Sequestering FGFs with GSK3052230 (FP-1039) blocks their ability to activate FGFRs while avoiding toxicities associated with small molecule inhibitors of FGFR, including
Autor:
Sanjay Goel, Jorge Luis Iglesias Dios, Eva M. Fernández-García, Cinthya Coronado, Bernardo Miguel-Lillo, Santiago Viteri, Teresa Moran, Rafael Rosell
Publikováno v:
Investigational New Drugs. 34:75-83
Objective To determine the recommended dose for phase II trials of elisidepsin (PM02734, Irvalec®) in combination with erlotinib in patients with advanced malignant solid tumors. Methods Open-label, dose-escalating, phase I study of intravenous elis